Physician profile
Kimberly A Schlichter
NPI 1881678282
$618.72
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $78.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.20 | 2019 | |
| Pfizer INC. | $79.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $70.91 | 2019-2020 | |
| Daiichi Sankyo INC. | $52.88 | 2019 | |
| Astellas Pharma US INC | $52.05 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.33 | 2019-2020 | |
| Therapeuticsmd, INC. | $35.12 | 2019-2020 | |
| Coopersurgical, INC. | $33.60 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.32 | 2019 | |
| Olympus America INC. | $23.63 | 2019 | |
| Roche Diagnostics Corporation | $17.45 | 2019 | |
| Allergan, INC. | $15.55 | 2019 | |
| Hologic Sales and Service, LLC | $15.33 | 2020 | |
| Duchesnay USA Incorporated | $13.52 | 2019 | |
| Exeltis, USA INC. | $12.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Schlichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.